Based on the largest and most extensive review of adherence studies to date.
Adherence in Africa will decline as great things about treatment plateau and long-term side effects accumulate and when people no longer see AIDS as a terminal disease. The task will be to identify and intervene on these declines prior to rising population degrees of resistance, stated Bangsberg. The review notes the World Health Organization’s intent to improve usage of antiretrovirals in Sub-Saharan Africa and its estimates of the proportion of HIV/AIDS patients urgently needing therapy. The estimates range from 56 % in Uganda and Botswana to 3.2 % in Tanzania and the Democratic Republic of Congo. When we talk about AIDS in Africa, it really is usually in broad terms–‘millions of people infected’ etc. To make policy, we must continually be mindful that we are discussing someone’s mother, daughter, brother, sister, father or son. (more…)